There are 2867 resources available
Invited Discussant LBA72, 904MO, 68MO and 1661MO
Presenter: Marleen Kok
Session: Mini Oral session: Basic science & translational research
Resources:
Slides
Webcast
The relevance of endoxifen measurements in the adjuvant tamoxifen treatment of breast cancer
Presenter: Stijn Koolen
Session: Insights in clinical pharmacology to optimise systemic anti-cancer treatment in daily practice
Resources:
Slides
Webcast
Primary CNS lymphoma: Discussant
Presenter: Andres Ferreri
Session: ESMO Clinical Practice Guidelines session 2
Resources:
Slides
Webcast
Limitations of clinical trials, alternative trial designs and the perspective of the clinician or patient
Presenter: Ann Partridge
Session: ESMO In collaboration with ASCO: The use of real-world data in guiding clinical practice
Resources:
Slides
Webcast
Other targets beyond DDR in ovarian cancer
Presenter: Isabelle Ray-Coquard
Session: Targeting DNA repair and beyond in ovarian cancer
Resources:
Slides
Webcast
1662MO - Longitudinal analysis of circulating immune cell subsets in melanoma patients (pts) treated with neo-adjuvant ipilimumab (ipi) & nivolumab (nivo)
Presenter: Rebecca Simpson
Session: Mini Oral session: Basic science & translational research
Resources:
Abstract
Slides
Webcast
1734MO - Hypoxic bladder cancers have a poorer outcome following hypofractionated vs conventionally fractionated radiotherapy in the BC2001 and BCON randomised trials
Presenter: Tim Smith
Session: Mini Oral session 1: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
Insfrastructure and policies for global clinical trials: Opportunities and threats
Presenter: Carlos Gomez-Roca
Session: Young Oncologist Masterclass: Clinical Trials Design and Development in the 21st Century
Resources:
Slides
Webcast
LBA54 - Three years survival outcome and continued cemiplimab (CEMI) beyond progression with the addition of chemotherapy (chemo) for patients (pts) with advanced non-small cell lung cancer (NSCLC): The EMPOWER-Lung 1 trial
Presenter: Mustafa Ozguroglu
Session: Proffered Paper session: NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
The rationale behind selecting recommended dose and schedule in immunotherapy ion
Presenter: Emiliano Calvo
Session: Insights in clinical pharmacology to optimise systemic anti-cancer treatment in daily practice
Resources:
Slides
Webcast